US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.095
  • -0.025-2.23%
Trading Nov 21 13:43 ET
166.54MMarket Cap-6843P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
Net income from continuing operations
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
39.26%-110.56M
46.03%-10.72M
40.33%-25.01M
25.37%-42.06M
48.71%-32.77M
17.52%-182.02M
63.64%-19.87M
Operating gains losses
----
----
----
-86.49%10K
---13K
--0
----
----
-91.00%74K
--0
Depreciation and amortization
-20.08%581K
-13.26%641K
-4.04%689K
0.35%2.9M
-9.61%715K
2.97%727K
10.13%739K
-0.42%718K
-4.37%2.89M
-0.38%791K
Other non cash items
416.44%377K
176.92%144K
174.51%140K
67.82%339K
226.00%163K
40.38%73K
4.00%52K
2.00%51K
-77.65%202K
0.00%50K
Change In working capital
-50.13%4.25M
-986.53%-3.42M
-1,811.36%-10.09M
259.81%16.79M
129.45%8.4M
224.00%8.53M
-97.71%386K
-106.59%-528K
70.05%-10.51M
-428.34%-28.53M
-Change in receivables
-48.29%6.67M
66.78%-8.39M
-962.73%-5.19M
51.13%-8.09M
137.10%3.66M
784.24%12.9M
-3,255.63%-25.25M
110.72%601K
-360.59%-16.55M
-229.97%-9.86M
-Change in inventory
-217.97%-3.09M
-105.26%-391K
-114.44%-363K
301.31%12.46M
95.59%-103K
-71.19%2.62M
253.38%7.44M
131.08%2.51M
4.42%-6.19M
66.08%-2.33M
-Change in prepaid assets
-2,330.23%-3.84M
-96.95%289K
-124.50%-222K
1,427.33%15.43M
203.58%4.89M
-89.43%172K
110.15%9.46M
323.70%906K
112.04%1.01M
-75.19%-4.72M
-Change in payables and accrued expense
162.98%4.51M
-41.98%5.07M
4.99%-4.32M
-126.82%-3.01M
99.67%-38K
54.42%-7.16M
-46.84%8.73M
-120.57%-4.55M
142.25%11.23M
-240.19%-11.61M
Cash from discontinued investing activities
Operating cash flow
136.73%3.37M
83.05%-4.6M
61.78%-9.52M
59.98%-58.79M
106.54%2.46M
75.24%-9.18M
4.26%-27.17M
43.33%-24.9M
27.76%-146.91M
17.07%-37.53M
Investing cash flow
Cash flow from continuing investing activities
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
Net PPE purchase and sale
45.65%-431K
-129.14%-637K
--0
4.13%-1.53M
42.34%-237K
-744.72%-793K
13.66%-278K
77.33%-224K
46.56%-1.6M
-14.80%-411K
Net investment purchase and sale
119.62%4.4M
-80.11%2.69M
-96.55%1.28M
1,231.34%19.53M
-453.58%-8.6M
37.99%-22.43M
-32.78%13.5M
210.52%37.06M
-104.83%-1.73M
110.18%2.43M
Cash from discontinued investing activities
Investing cash flow
117.10%3.97M
-84.51%2.05M
-96.53%1.28M
641.37%18M
-537.21%-8.84M
35.58%-23.22M
-33.09%13.22M
236.51%36.83M
-110.16%-3.32M
108.33%2.02M
Financing cash flow
Cash flow from continuing financing activities
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
Net issuance payments of debt
----
----
----
--24.35M
--0
----
----
----
--0
--0
Net common stock issuance
----
----
----
-60.40%29.76M
--0
----
----
----
--75.15M
---18K
Proceeds from stock option exercised by employees
104.55%14K
54.23%492K
105.29%11K
102.33%2K
-56.46%199K
-39.37%-308K
1.27%319K
67.35%-208K
-101.22%-86K
-6.16%457K
Cash from discontinued financing activities
Financing cash flow
-99.97%14K
54.23%492K
105.29%11K
-27.91%54.11M
-54.67%199K
-28.22%53.8M
1.27%319K
67.35%-208K
-51.89%75.06M
-9.86%439K
Net cash flow
Beginning cash position
36.58%18.39M
-24.51%20.45M
86.65%28.68M
-83.03%15.36M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-13.88%90.54M
-68.39%50.44M
Current changes in cash
-65.63%7.36M
84.85%-2.06M
-170.16%-8.23M
117.71%13.31M
82.37%-6.18M
1,069.87%21.4M
-64.15%-13.63M
134.87%11.73M
-415.02%-75.18M
49.19%-35.07M
End cash Position
-26.16%25.74M
36.58%18.39M
-24.51%20.45M
86.65%28.68M
86.65%28.68M
-30.89%34.86M
-72.31%13.46M
-52.40%27.09M
-83.03%15.36M
-83.03%15.36M
Free cash flow
129.48%2.94M
80.90%-5.24M
62.12%-9.52M
59.44%-60.33M
105.81%2.21M
73.13%-9.97M
4.36%-27.44M
44.15%-25.12M
27.93%-148.74M
16.87%-37.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M
Net income from continuing operations 80.61%-4.85M78.04%-9.24M90.36%-3.16M39.26%-110.56M46.03%-10.72M40.33%-25.01M25.37%-42.06M48.71%-32.77M17.52%-182.02M63.64%-19.87M
Operating gains losses -------------86.49%10K---13K--0---------91.00%74K--0
Depreciation and amortization -20.08%581K-13.26%641K-4.04%689K0.35%2.9M-9.61%715K2.97%727K10.13%739K-0.42%718K-4.37%2.89M-0.38%791K
Other non cash items 416.44%377K176.92%144K174.51%140K67.82%339K226.00%163K40.38%73K4.00%52K2.00%51K-77.65%202K0.00%50K
Change In working capital -50.13%4.25M-986.53%-3.42M-1,811.36%-10.09M259.81%16.79M129.45%8.4M224.00%8.53M-97.71%386K-106.59%-528K70.05%-10.51M-428.34%-28.53M
-Change in receivables -48.29%6.67M66.78%-8.39M-962.73%-5.19M51.13%-8.09M137.10%3.66M784.24%12.9M-3,255.63%-25.25M110.72%601K-360.59%-16.55M-229.97%-9.86M
-Change in inventory -217.97%-3.09M-105.26%-391K-114.44%-363K301.31%12.46M95.59%-103K-71.19%2.62M253.38%7.44M131.08%2.51M4.42%-6.19M66.08%-2.33M
-Change in prepaid assets -2,330.23%-3.84M-96.95%289K-124.50%-222K1,427.33%15.43M203.58%4.89M-89.43%172K110.15%9.46M323.70%906K112.04%1.01M-75.19%-4.72M
-Change in payables and accrued expense 162.98%4.51M-41.98%5.07M4.99%-4.32M-126.82%-3.01M99.67%-38K54.42%-7.16M-46.84%8.73M-120.57%-4.55M142.25%11.23M-240.19%-11.61M
Cash from discontinued investing activities
Operating cash flow 136.73%3.37M83.05%-4.6M61.78%-9.52M59.98%-58.79M106.54%2.46M75.24%-9.18M4.26%-27.17M43.33%-24.9M27.76%-146.91M17.07%-37.53M
Investing cash flow
Cash flow from continuing investing activities 117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M
Net PPE purchase and sale 45.65%-431K-129.14%-637K--04.13%-1.53M42.34%-237K-744.72%-793K13.66%-278K77.33%-224K46.56%-1.6M-14.80%-411K
Net investment purchase and sale 119.62%4.4M-80.11%2.69M-96.55%1.28M1,231.34%19.53M-453.58%-8.6M37.99%-22.43M-32.78%13.5M210.52%37.06M-104.83%-1.73M110.18%2.43M
Cash from discontinued investing activities
Investing cash flow 117.10%3.97M-84.51%2.05M-96.53%1.28M641.37%18M-537.21%-8.84M35.58%-23.22M-33.09%13.22M236.51%36.83M-110.16%-3.32M108.33%2.02M
Financing cash flow
Cash flow from continuing financing activities -99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K
Net issuance payments of debt --------------24.35M--0--------------0--0
Net common stock issuance -------------60.40%29.76M--0--------------75.15M---18K
Proceeds from stock option exercised by employees 104.55%14K54.23%492K105.29%11K102.33%2K-56.46%199K-39.37%-308K1.27%319K67.35%-208K-101.22%-86K-6.16%457K
Cash from discontinued financing activities
Financing cash flow -99.97%14K54.23%492K105.29%11K-27.91%54.11M-54.67%199K-28.22%53.8M1.27%319K67.35%-208K-51.89%75.06M-9.86%439K
Net cash flow
Beginning cash position 36.58%18.39M-24.51%20.45M86.65%28.68M-83.03%15.36M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-13.88%90.54M-68.39%50.44M
Current changes in cash -65.63%7.36M84.85%-2.06M-170.16%-8.23M117.71%13.31M82.37%-6.18M1,069.87%21.4M-64.15%-13.63M134.87%11.73M-415.02%-75.18M49.19%-35.07M
End cash Position -26.16%25.74M36.58%18.39M-24.51%20.45M86.65%28.68M86.65%28.68M-30.89%34.86M-72.31%13.46M-52.40%27.09M-83.03%15.36M-83.03%15.36M
Free cash flow 129.48%2.94M80.90%-5.24M62.12%-9.52M59.44%-60.33M105.81%2.21M73.13%-9.97M4.36%-27.44M44.15%-25.12M27.93%-148.74M16.87%-37.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data